Operating Segments (Tables)

9 Months Ended

Jun. 30, 2012

Operating Segments [Abstract]

Schedule of segment revenue operating income from continuing operations and depreciation and amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, as follows (in thousands):

	Three months ended June 30,						Nine months ended June 30,
	2012			2011			2012			2011
Revenue:
Medical Device	$	10,269		$	9,559		$	27,889		$	29,372
In Vitro Diagnostics		3,690			3,440			10,196			9,483
Total revenue	$	13,959		$	12,999		$	38,085		$	38,855
Operating income (loss):
Medical Device	$	5,173		$	4,574		$	13,226		$	15,035
In Vitro Diagnostics		1,070			1,439			3,246			3,354
Corporate		(1,450	)		(1,756	)		(4,768	)		(5,799	)
Total operating income from continuing operations	$	4,793		$	4,257		$	11,704		$	12,590
Depreciation and amortization:
Medical Device	$	355		$	397		$	1,073		$	1,230
In Vitro Diagnostics		193			200			582			598
Corporate		186			192			559			565
Total depreciation and amortization	$	734		$	789		$	2,214		$	2,393